Andrographolide engineered gold nanoparticle to overcome drug resistant visceral leishmaniasis. (31st October 2018)
- Record Type:
- Journal Article
- Title:
- Andrographolide engineered gold nanoparticle to overcome drug resistant visceral leishmaniasis. (31st October 2018)
- Main Title:
- Andrographolide engineered gold nanoparticle to overcome drug resistant visceral leishmaniasis
- Authors:
- Das, Suvadra
Halder, Asim
Mandal, Saptarshi
Mazumder, Mohammad Abu Jafar
Bera, Tanmoy
Mukherjee, Arup
Roy, Partha - Abstract:
- Abstract: Visceral leishmaniasis (VL) is World Health Organization designated most serious leishmaniasis with an annual mortality rate of 50, 000. Even after country specific eradication programs, the disease continues to multiply with added complexities like resistance development, drug hypersensitivity and associated infections. Newer therapeutic interventions are urgently warranted to control the spread. Present study aims to arrive at terpenoid andrographolide engineered gold nanoparticle (AGAunps) facile synthesis and its efficacy evaluations against wild and drug resistant VL strains for the first time. Molecular bio-organic conjugation of AGAunp was confirmed in FT-IR and EDAX studies. Nano-gold plasmon response was recorded at 543 nm and the average size in TEM was 14 nm. SAED pattern and XRD observations proved fcc crystalline structure of nano-gold. AGAunp recorded spherical geometry in AFM and TEM. PDI value of 0.137 revealed the monodisperse nature of the nano-scale population. AGAunp exhibited strong antileishmanicidal effect both against wild type (IC50 19 ± 1.7 µM) and sodium stibogluconate (IC50 55 ± 7.3 µM)/paromomycin (IC50 41 ± 6 µM) resistant strains. Complete macrophage uptake AGAunp's occured within two hours exposure. AGAunp macrophage cytotoxicity was significantly lower as compared to Amphotericin-B. Low toxic Andrographolide engineered gold nanoparticle emerged as promising alternatives in the control of wild and drug resistant VL. GraphicalAbstract: Visceral leishmaniasis (VL) is World Health Organization designated most serious leishmaniasis with an annual mortality rate of 50, 000. Even after country specific eradication programs, the disease continues to multiply with added complexities like resistance development, drug hypersensitivity and associated infections. Newer therapeutic interventions are urgently warranted to control the spread. Present study aims to arrive at terpenoid andrographolide engineered gold nanoparticle (AGAunps) facile synthesis and its efficacy evaluations against wild and drug resistant VL strains for the first time. Molecular bio-organic conjugation of AGAunp was confirmed in FT-IR and EDAX studies. Nano-gold plasmon response was recorded at 543 nm and the average size in TEM was 14 nm. SAED pattern and XRD observations proved fcc crystalline structure of nano-gold. AGAunp recorded spherical geometry in AFM and TEM. PDI value of 0.137 revealed the monodisperse nature of the nano-scale population. AGAunp exhibited strong antileishmanicidal effect both against wild type (IC50 19 ± 1.7 µM) and sodium stibogluconate (IC50 55 ± 7.3 µM)/paromomycin (IC50 41 ± 6 µM) resistant strains. Complete macrophage uptake AGAunp's occured within two hours exposure. AGAunp macrophage cytotoxicity was significantly lower as compared to Amphotericin-B. Low toxic Andrographolide engineered gold nanoparticle emerged as promising alternatives in the control of wild and drug resistant VL. Graphical Abstract: UF0001 … (more)
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 46(2018)Supplement 1
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 46(2018)Supplement 1
- Issue Display:
- Volume 46, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 46
- Issue:
- 1
- Issue Sort Value:
- 2018-0046-0001-0000
- Page Start:
- 751
- Page End:
- 762
- Publication Date:
- 2018-10-31
- Subjects:
- Visceral leishmaniasis -- terpenoid -- andrographolide -- engineered gold nanoparticle -- drug resistant -- low-toxic
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2018.1435549 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26872.xml